Insight

David J. Benjamin: What is important to individuals being treated for locally advanced/metastatic urothelial carcinoma

David J. Benjamin/X

Sep 5, 2024, 07:11

David J. Benjamin: What is important to individuals being treated for locally advanced/metastatic urothelial carcinoma

David J. Benjamin, Hematology-Oncology specialist, shared a post on X:

“Congratulations Andrea Apolo and colleagues on the latest publication in Patient Journal. With a growing armamentarium of therapies, it is critical for oncologists to understand what is important to individuals being treated for locally advanced/metastatic urothelial carcinoma.”

Patient Preferences for First-Line Treatment of Locally Advanced or Metastatic Urothelial Carcinoma: An Application of Multidimensional Thresholding

Authors: Andrea B. Apolo, Christine Michaels-Igbokwe, Nicholas I. Simon, David J. Benjamin, Mallory Farrar, Zsolt Hepp, Lisa Mucha, Sebastian Heidenreich, Katelyn Cutts, Nicolas Krucien, Natasha Ramachandran & John L. Gore

Source: David J. Benjamin/X

Andrea Apolo Andrea B Apolo cancer cancer awareness Christine Michaels-Igbokwe David J. Benjamin John L. Gore Katelyn Cutts Lisa Mucha Mallory Farrar Natasha Ramachandran Nicholas I Simon Nicolas Krucien OncoDaily Oncology Patient Journal Sebastian Heidenreich Zsolt Hepp

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Garo Armen - A Bold Call to Action: Embracing Real-Time Innovation in Pediatric Cancer